Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3903106
Max Phase: Preclinical
Molecular Formula: C17H17ClN2O2
Molecular Weight: 316.79
Molecule Type: Small molecule
Associated Items:
ID: ALA3903106
Max Phase: Preclinical
Molecular Formula: C17H17ClN2O2
Molecular Weight: 316.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1ccc(C2CNCCO2)cc1)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C17H17ClN2O2/c18-14-5-1-13(2-6-14)17(21)20-15-7-3-12(4-8-15)16-11-19-9-10-22-16/h1-8,16,19H,9-11H2,(H,20,21)
Standard InChI Key: KGPOKGIHPOHHOL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 316.79 | Molecular Weight (Monoisotopic): 316.0979 | AlogP: 3.25 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.36 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.11 | CX LogP: 3.07 | CX LogD: 2.28 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.91 | Np Likeness Score: -1.06 |
1. (2016) Substituted benzamides, |
Source(1):